{
    "organizations": [],
    "uuid": "052d6f0b07bbcb4de063fc58b507d36b73748753",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alteogen-receives-us-patent/brief-alteogen-receives-u-s-patent-idUSL3N1S71FS",
    "ord_in_thread": 0,
    "title": "BRIEF-Alteogen receives U.S. patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Alteogen Inc :\n* Says it received U.S. patent, for a stable liquid formulation of fusion protein with IgG Fc domain\nSource text in Korean : goo.gl/Xg43XN\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-30T09:34:00.000+03:00",
    "crawled": "2018-04-30T13:16:31.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "alteogen",
        "inc",
        "say",
        "received",
        "patent",
        "stable",
        "liquid",
        "formulation",
        "fusion",
        "protein",
        "igg",
        "fc",
        "domain",
        "source",
        "text",
        "korean",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}